Isoplexis

Developer of multiplexed single-cell analysis tools for the diagnostics and life science research

placeNew Haven, Connecticut, United States calendar_todayFounded 2012 groups195 employees language isoplexis.com

Registered entities

Innovation

22 patent families (13 granted) — focus: Chemistry & metallurgy, Physics & computing, Operations & transport; filing pace slowing. Cited 4,623 times.

YearFilings
20161
20171
20183
20194
20204
20217
202212
20239
20248
20255
20262

Investor mix

16 investors on record; lead investors include Northpond Ventures, Connecticut Innovations, Spring Mountain Capital, Perceptive Advisors; 1 has since exited.

Investor typeCountShare
Venture capital638%
Private equity319%
Other / undisclosed744%
Coming soon